Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]

Article information

Clin Mol Hepatol. 2025;31(2):669-670
Publication date (electronic) : 2025 February 27
doi : https://doi.org/10.3350/cmh.2024.0333e
1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea
3Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea
4Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
5Department of Surgery, Korea University Guro Hospital, Seoul, Korea
6Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, Korea
7Department of Medicine, Graduate School, Kyung Hee University, Seoul, Korea
8Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
9Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
10Department of Biomedical Sciences, Dong-A University, Busan, Korea
11Department of Health Sciences, The Graduate School of Dong-A University, Busan, Korea
12Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Corresponding author : Ju-Seog Lee Department of Systems Biology, Unit 1058, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA Tel: +1-713-834-6154, Fax: +1-713-563-4235, E-mail: jlee@mdanderson.org
*These authors equally contributed to the writing of this manuscript.

In the original publication of this paper, the second graph in Figure 4B was erroneously identical with fourth graph in Figure 4B and correct version is provided below. We apologize for any inconvenience that may have been caused.

The original article has been corrected as of 27th February 2025.

Before correction

Figure 4B.

After correction

Figure 4B.

Article information Continued